Previous close | 12.68 |
Open | 12.79 |
Bid | 12.56 x 800 |
Ask | 13.16 x 1300 |
Day's range | 12.70 - 13.28 |
52-week range | 10.48 - 26.89 |
Volume | |
Avg. volume | 443,611 |
Market cap | 571.895M |
Beta (5Y monthly) | 1.64 |
PE ratio (TTM) | N/A |
EPS (TTM) | -1.92 |
Earnings date | 07 Nov 2023 - 13 Nov 2023 |
Forward dividend & yield | N/A (N/A) |
Ex-dividend date | N/A |
1y target est | 25.14 |
BLFS, ALCO and AFCG have been added to the Zacks Rank #5 (Strong Sell) List on September 13, 2023.
Shares of BioLife Solutions (NASDAQ: BLFS) were down more than 37% for the week, as of 3:15 p.m. ET on Friday, according to data provided by S&P Global Market Intelligence. BioLife is a cell- and gene-therapy bioproduction tools and services company. It makes cell-storage media, thawing solutions, cold chain accessories, and cryopreservation freeze media products.
Market forces rained on the parade of BioLife Solutions, Inc. ( NASDAQ:BLFS ) shareholders today, when the analysts...